IL115177A0 - Phosphorus-32 labeling of antibodies for cancer therapy - Google Patents

Phosphorus-32 labeling of antibodies for cancer therapy

Info

Publication number
IL115177A0
IL115177A0 IL11517795A IL11517795A IL115177A0 IL 115177 A0 IL115177 A0 IL 115177A0 IL 11517795 A IL11517795 A IL 11517795A IL 11517795 A IL11517795 A IL 11517795A IL 115177 A0 IL115177 A0 IL 115177A0
Authority
IL
Israel
Prior art keywords
labeling
antibodies
phosphorus
cancer therapy
cancer
Prior art date
Application number
IL11517795A
Other languages
English (en)
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of IL115177A0 publication Critical patent/IL115177A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11517795A 1994-09-16 1995-09-05 Phosphorus-32 labeling of antibodies for cancer therapy IL115177A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30810394A 1994-09-16 1994-09-16

Publications (1)

Publication Number Publication Date
IL115177A0 true IL115177A0 (en) 1995-12-31

Family

ID=23192557

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11517795A IL115177A0 (en) 1994-09-16 1995-09-05 Phosphorus-32 labeling of antibodies for cancer therapy

Country Status (6)

Country Link
EP (1) EP0783516A4 (de)
JP (1) JPH10511263A (de)
AU (1) AU3548895A (de)
CA (1) CA2200088A1 (de)
IL (1) IL115177A0 (de)
WO (1) WO1996008506A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
AU2003251674B2 (en) * 2002-08-19 2009-09-03 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
CN101972478B (zh) 2002-10-08 2012-10-31 免疫医疗公司 抗体治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
US4923802A (en) * 1985-06-13 1990-05-08 Immunex Corporation Peptide substrates for the detection, characterization and purification of protein kinase C
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins
GB8906708D0 (en) * 1989-03-23 1989-05-10 Foxwell Brian M J Improvements relating to the radiolabelling of proteins
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
DE69233214T2 (de) * 1991-04-19 2004-07-01 The Board Of Regents Of The University Of Washington, Seattle Für säugetierphosphodiesterasen kodierende dns
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
US5366889A (en) * 1992-11-30 1994-11-22 The General Hospital Corporation DNA encoding a protein-coupled receptor kinase

Also Published As

Publication number Publication date
CA2200088A1 (en) 1996-03-21
EP0783516A4 (de) 1999-09-15
EP0783516A1 (de) 1997-07-16
AU3548895A (en) 1996-03-29
JPH10511263A (ja) 1998-11-04
WO1996008506A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
ZA9811314B (en) Novel compounds and methods for synthesis and therapy
IL234696A (en) Anti-erbb2 antibodies for the treatment of cancer drugs.
IL131560A0 (en) Compounds for immunotherapy of prostate cancer and methods for their use
ZA9533B (en) Pentolifylline therapy
GB2318734B (en) Methods of preventing breast cancer
HK1120494A1 (en) Novel compounds and methods for synthesis and therapy
GB9410320D0 (en) Novel therapeutic method
GB9509572D0 (en) Cancer therapy
HUP9900011A3 (en) Use of protein gax for treating cancer
IL115177A0 (en) Phosphorus-32 labeling of antibodies for cancer therapy
GB9308166D0 (en) Cancer therapy
GB9703633D0 (en) Cancer therapy
GB9513969D0 (en) Magnetic therapy system
GB2312375B (en) Agents for treatment of cancer
ZA988451B (en) Novel compounds and methods for synthesis and therapy
GB9504415D0 (en) Novel treatments for cancer
GB9624800D0 (en) Methods of preventing breast cancer
GB9701876D0 (en) Cancer therapy
IL120901A0 (en) Cancer therapy
ZA981585B (en) Compounds for immunotherapy of prostate cancer and methods for their use
GB9416932D0 (en) Tumour specific photeoglycan
GB9417061D0 (en) Novel method of therapy
AU2003204079A1 (en) Novel compounds and methods for synthesis and therapy
ZA95941B (en) Liphophilic carrier preparations
GB9512868D0 (en) Therapeutic compounds